MicroRNA-98 reduces nerve growth factor expression in nicotine-induced airway remodeling

Area of Science:

• Pulmonary Medicine
• Molecular Biology
• Asthma Research

Background:

• Nicotine exposure is linked to impaired asthma control.
• Nerve growth factor (NGF) is implicated in airway remodeling and hyperresponsiveness.
• MicroRNA-98 (miR-98) and PPARγ are potential regulators of NGF and airway remodeling.

Purpose of the Study:

• To investigate if nicotine increases NGF by reducing miR-98 and PPARγ levels in lung fibroblasts (LFs).
• To explore the role of miR-98 and PPARγ in nicotine-induced airway remodeling.
• To determine if modulating miR-98 or PPARγ can reverse nicotine's effects on airway remodeling markers.

Main Methods:

• Measured NGF, miR-98, PPARγ, and airway remodeling markers (FN1, ET-1, COL1A1, COL3A1) in human and mouse LFs and mouse lung homogenates.
• Exposed LFs and mice to nicotine.
• Manipulated miR-98 levels using inhibitors and mimics, and PPARγ using rosiglitazone.

Main Results:

• Nicotine increased NGF, FN1, ET-1, COL1A1, and COL3A1 expression in LFs and lung homogenates.
• Nicotine reduced miR-98 levels in LFs and lung homogenates.
• miR-98 inhibition mimicked nicotine's effects, while miR-98 mimic and rosiglitazone reversed them.

Conclusions:

• Nicotine-induced increases in NGF and airway remodeling markers are negatively regulated by miR-98.
• Restoring miR-98 levels or activating PPARγ can counteract nicotine's detrimental effects on airways.
• miR-98 represents a potential therapeutic target for managing nicotine-related asthma exacerbations.